Formulation and Evaluation of Bilayer Tablets of Granisetron HCl and Ibuprofen for the Treatment of Migraine
DOI:
https://doi.org/10.37285/ijpsn.2024.17.5.6Abstract
Background of the Topic: The major purpose of this study was to produce a bilayer pill that contained Granisetron HCl (GSH) and ibuprofen (IBF) in distinct layers to minimize the possibility of adverse drug interactions and maximize the efficacy of both medications when they were combined to treat the symptoms of migraines. In contrast to the IBF layer, the GSH layer was intended to have a more gradual release of its contents.
Methods: Microcrystalline cellulose, sodium starch glycolate, and croscarmellose sodium were the chemicals used to create the rapid-release layer. Isopropyl alcohol, magnesium stearate, and HPMC K 4M were among the polymers and gums that were used in the process of producing the continuous release layer. First, the fine-tuning process was performed on the tablet's two layers. After that, the layers necessary for quick as well as extended-release were put together. There were no adverse reactions caused by the active components interacting with the excipients. The rate at which a medicine is absorbed into the body may be sped up by using Croscarmellose sodium in a formulation.
Results: A combination is given a delayed release influence by the addition of HPMC K 4M. The bilayer tablet forms from the improved (IR-4) batch were found to have strong linearity as shown by the regression coefficient of 0.9773, which is a first-order equation. According to the results, a bilayer pill that has both an increased IR-4 GSH immediate release layer and an SR-5 IBF sustained release layer would be an effective way to treat migraines.
Conclusion: Bilayer tablets with releasing qualities provide a wide variety of benefits, some of which include the ability to localize medication administration, enhanced absorption, and improved effectiveness.
Downloads
Keywords:
Granisetron HCl, Ibuprofen, Bilayer tablets, Migraine
Published
How to Cite
Issue
Section
References
Snow V, Weiss K, Wall EM, Mottur-Pilson C, American Academy of Family Physicians and the American College of Physicians–American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Annals of internal medicine. 2002 Nov 19; 137(10):840-9.
Late SG, Banga AK. Response surface methodology to optimize novel fast disintegrating tablets using β cyclodextrin as diluent. AAPS Pharm SciTech. 2010 Dec; 11:1627-35.
Reddy KR, Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS pharm SciTech. 2003 Dec; 4:480-8.
Savaşer A, Özkan Y, Işımer A. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium. Il Farmaco. 2005 Feb 1;60(2):171-7.
Lopes CM, Sousa Lobo JM, Costa P, Pinto JF. Directly compressed mini matrix tablets containing Ibuprofen: preparation and evaluation of sustain release. Drug Dev Ind Pharm.2006; 32(1):95-106.
Shoaib MH, Tazeen J, Merchant HA, Yousuf RI. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak J Pharm Sci.2006:19(2): 119-24.
Cox PJ, Khan KA, Munday DL, Sujja-Areevath J. Development and evaluation of a multiple-unit oral sustained release dosage form for S (+)-ibuprofen: preparation and release kinetics. International journal of pharmaceutics. 1999 Dec 20;193(1):73-84.
Mizumoto T, Masuda Y, Yamamoto T, Yonemochi E, Terada K. Formulation design of a novel fast-disintegrating tablet. International journal of Pharmaceutics. 2005 Dec 8;306(1-2):83-90.
Rajanikant P, Nirav P, Patel NM, Patel MM. A novel approach for dissolution enhancement of Ibuprofen by preparing floating granules. Int. J. Res. Pharm. Sci. 2010;1(1):57-64.
Greenhalgh DJ, Williams AC, Timmins P, York P. Solubility parameters as predictors of miscibility in solid dispersions. Journal of pharmaceutical sciences. 1999 Nov 1;88(11):1182-90.
Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug discovery today. 2007 Dec 1;12(23-24):1068-75.
Mehlisch DR, Ardia A, Pallotta T. A controlled comparative study of ibuprofen arginate versus conventional ibuprofen in the treatment of postoperative dental pain. The Journal of Clinical Pharmacology. 2002 Aug;42(8):904-11.
Aapro M. Granisetron: an update on its clinical use in the management of nausea and vomiting. The oncologist. 2004 Nov;9(6):673-86.
Ho KY, Gan TJ. Pharmacology, pharmacokinetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Current Opinion in Anesthesiology. 2006 Dec 1;19(6):606-11.
Gebbia V, Cannata G, Testa A, Gurto G, Valenza R, Cipolla C, Lattri MA, Gebbia N. Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial. Cancer. 1994 Oct 1;74(7):1945-52.
Ray D, Prusty AK. Designing and in-vitro studies of gastric floating tablets of tramadol hydrochloride. International journal of applied pharmaceutics. 2010;2(4):12-6.
Gupta MM, Srivastava B. Enhancement of flow property of poorly flow able aceclofenac drug powder by preparation of spherical crystals using solvent change method and making drug powder suitable for direct compression. Int J Current Pharm Res Re. 2010 May; 1:12-23.
Basavaraj KN, Mhase SR, Manvi FV. Preparation and evaluation of biphasic release tablet formulation for the treatment of diabetes mellitus. Int J Novel Drug Deliv Tech. 2011;1(1):1-1.
Derosa G, Salvadeo SA. Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy. Core Evidence. 2007;2(3):189.
Patel D, Patel A, Solanki T. Formulation and evaluation of bilayer tablet by using melt granulation technique for treatment of diabetes mellitus. Journal of Pharmacy & Bio allied Sciences. 2012 Mar;4(Supple 1): S37.
